Why Everyone on Reddit Is Suddenly Obsessed With Retatrutide

What retatrutide is (the short version)

Retatrutide is an experimental compound from Eli Lilly. It's often called a "triple agonist" or "triple G" because it acts on three receptors at once: GLP-1, GIP, and glucagon. Tirzepatide hits two of those. Semaglutide hits one.

That extra glucagon piece is the part that gets people excited. In theory, it nudges energy use up instead of only dialing appetite down. That's the theory, anyway. It's still being studied.

Here's the fact people gloss over: retatrutide is not approved by the FDA. It's in phase 3 trials right now. Anything sold online is a research compound, not a medication.

The trial numbers driving the retatrutide Reddit hype

The reason the subs lit up is a phase 2 trial published in 2023. Participants in the top study group lost around 24% of their body weight over 48 weeks. For context, tirzepatide's big trial showed roughly 20% at 72 weeks, and semaglutide landed around 15%.

Reddit loves a leaderboard. When one number beats the others, that number becomes the whole conversation. You'll see the "24%" figure quoted in nearly every thread, often without the caveat that phase 2 trials are smaller and phase 3 results are still coming.

The more careful posters point this out. They get a few upvotes. The hype posts get hundreds.

The three things every thread turns into

Read enough of these and the same pattern shows up.

Dosing. It's the number one topic by a mile. I'm not going there, and neither should any blog. This is an unapproved compound, and Reddit strangers are not a substitute for a clinical trial protocol.

Side effects. Nausea and stomach issues come up constantly, same as with the other GLP-1 compounds. Some posters also mention heart rate changes, which were noted in the trial data too. The tone here is more honest than the hype posts.

Sourcing. This is where things get spicy. Because retatrutide isn't a prescription product, there's no pharmacy route. Everything runs through research vendors. So the threads are full of "who's legit," "is this COA real," and "my vendor vanished overnight."

Why sourcing is such a mess right now

The vendor scene has been rough. Peptide Sciences reportedly closed in early 2026. Amino Asylum was reportedly raided in 2025. Lilly and Novo have been suing compounders and sellers over tirzepatide and semaglutide, and the FDA pulled both off the shortage list, which squeezed the compounding pipeline.

So a lot of buyers migrated to research vendors, and a lot of research vendors are sketchy. Crypto-only checkout. COAs that look like they were made in Microsoft Paint. Shipping that takes three weeks and arrives warm.

That's why the "vendor vetting" posts get so much traffic. People are burned and cautious.

What the careful posters look for

When you filter out the astroturfed vendor lists, the sensible advice is pretty consistent:

• Third-party testing you can actually see, tied to the batch you're buying
• Purity numbers, not vague "pharma grade" claims
• Cold-chain shipping that arrives fast
• Normal payment options, not crypto-only
• A company that answers emails

This is where a vendor like Exactide comes up in a good light. They sell research-grade retatrutide with batch-specific COAs, verified at 99% purity or higher, and it ships domestically in 2 to 4 business days in cold packaging. Free shipping over $150 and regular payment methods. That checks most of the boxes the cautious crowd cares about.

My take after a month of reading

The obsession makes sense. The trial data is real and it's impressive. But Reddit turns every promising compound into a certainty, and retatrutide is still a phase 3 research molecule.

If you're doing legitimate research and need reliable material, skip the vendor-list lottery and go somewhere that publishes its lab work. Exactide's research-grade retatrutide is a solid place to start.